INDUCTION OF PROTECTIVE HUMAN ANTIINFLUENZA ANTIBODY IN THE HU-PBL/SCID MOUSE

被引：0
|
作者：
ALBERT, S [1 ]
PESTER, A [1 ]
CHAMBERLAIN, J [1 ]
机构：
[1] HOSP SICK CHILDREN,RES INST,TORONTO,ON M5G 1X8,CANADA
来源：
FASEB JOURNAL | 1995年 / 9卷 / 04期
关键词：
D O I：
暂无
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
引用
收藏
页码：A809 / A809
页数：1
相关论文
共 50 条
  • [41] THE HU-PBL-SCID MOUSE MODEL - LONG-TERM HUMAN SEROLOGIC EVOLUTION ASSOCIATED WITH THE XENOGENEIC TRANSFER OF HUMAN PERIPHERAL-BLOOD LEUKOCYTES INTO SCID MICE
    DUCHOSAL, MA
    EMING, SA
    MCCONAHEY, PJ
    DIXON, FJ
    CELLULAR IMMUNOLOGY, 1992, 139 (02) : 468 - 477
  • [42] LONG-TERM HUMAN HEMATOPOIESIS IN THE SCID-HU MOUSE
    NAMIKAWA, R
    WEILBAECHER, KN
    KANESHIMA, H
    YEE, EJ
    MCCUNE, JM
    JOURNAL OF EXPERIMENTAL MEDICINE, 1990, 172 (04): : 1055 - 1063
  • [43] A new Hu-PBL model for the study of human islet alloreactivity based on NOD-scid mice bearing a targeted mutation in the IL-2 receptor gamma chain gene
    King, Marie
    Pearson, Todd
    Shultz, Leonard D.
    Leif, Jean
    Bottino, Rita
    Trucco, Massimo
    Atkinson, Mark A.
    Wasserfall, Clive
    Herold, Kevan C.
    Woodland, Robert T.
    Schmidt, Madelyn R.
    Woda, Bruce A.
    Thompson, Michael J.
    Rossini, Aldo A.
    Greiner, Date L.
    CLINICAL IMMUNOLOGY, 2008, 126 (03) : 303 - 314
  • [44] Development of vaccines and passive immunotherapy against SARS coronavirus using mouse and SCID-PBL/hu mouse models
    Okada, Masaji
    Takemoto, Yuji
    Okuno, Yoshinobu
    Hashimoto, Satomi
    Fukunaga, Yukari
    Tanaka, Takao
    Kita, Yoko
    Kuwayama, Sechiko
    Muraki, Yumiko
    Kanamaru, Noriko
    Takai, Hiroko
    Okada, Chika
    Sakaguchi, Yayoi
    Furukawa, Izumi
    Yamada, Kyoko
    Izumiya, Miwa
    Yoshida, Shigeto
    Matsumoto, Makoto
    Kase, Tetsuo
    Peiris, J. S. M.
    deMello, Daphne E.
    Chen, Pei-Jer
    Yamamoto, Naoki
    Yoshinaka, Yoshiyuki
    Nomura, Tatsuji
    Ishida, Isao
    Morikawa, Shigeru
    Tashiro, Masato
    Sakatani, Mitsunori
    NIDOVIRUSES: TOWARD CONTROL OF SARS AND OTHER NIDOVIRUS DISEASES, 2006, 581 : 561 - 566
  • [45] HUMAN T-CELLS THAT POPULATE LONG-TERM HU-PBL-SCID CHIMERAS ARE ANTI-MOUSE REACTIVE
    TARYLEHMANN, M
    LEHMANN, PV
    SAXON, A
    FASEB JOURNAL, 1994, 8 (05): : A754 - A754
  • [46] Human immunoglobulins produced in hu-PBL-SCID mice are polyclonal early after xenotransplantation
    Tissot, JD
    Schneider, P
    Schapira, M
    Duchosal, MA
    CELLULAR IMMUNOLOGY, 1996, 167 (02) : 241 - 248
  • [47] EFFECTS OF HIV-INFECTION IN HUMAN THYMUS IN THE SCID-HU MOUSE
    KANESHIMA, H
    BONYHADI, ML
    MCCUNE, JM
    JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES AND HUMAN RETROVIROLOGY, 1993, 6 (06): : 741 - 741
  • [48] Passive immunization with a human monoclonal antibody protects hu-PBL-SCID mice against challenge by primary isolates of HIV-1
    Gauduin, MC
    Parren, PWHI
    Weir, R
    Barbas, CF
    Burton, DR
    Koup, RA
    NATURE MEDICINE, 1997, 3 (12) : 1389 - 1393
  • [49] Passive immunization with a human monoclonal antibody protects hu-PBL-SCID mice against challenge by primary isolates of HIV-1
    Marie-Claire Gauduin
    Paul W.H.I. Parren
    Raymond Weir
    Carlos F. Barbas
    Dennis R. Burton
    Richard A. Koup
    Nature Medicine, 1997, 3 : 1389 - 1393
  • [50] The development of DNA vaccines and passive immunotherapy against SARS coronavirus using mouse and SCID-PBL/hu mouse models
    Okada, M
    Takemoto, Y
    Okuno, Y
    Hashimoto, S
    Fukunaga, Y
    Tanaka, T
    Kita, Y
    Kuwayama, S
    Muraki, Y
    Kanamaru, N
    Takai, H
    Okada, C
    Sakaguchi, Y
    Furukawa, I
    Yamada, K
    Izumiya, M
    Yoshida, S
    Matsumoto, M
    Kase, T
    Peiris, M
    Ishida, I
    Morikawa, S
    Tashiro, M
    Sakatani, M
    FASEB JOURNAL, 2005, 19 (04): : A895 - A895
12345